Product Code: GVR-4-68040-512-5
Ultra-High Pressure Balloon Catheter Market Growth & Trends:
The global ultra-high pressure balloon catheter market size is anticipated to reach USD 775.7 million by 2030 and is anticipated to grow at a CAGR of 9.42% during the forecast period, according to a new report by Grand View Research, Inc. The ultra-high pressure balloon catheter industry is experiencing significant growth due to rising prevalence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease and growing adoption of minimally invasive procedures. For instance, the World Health Organization (WHO) reported that cardiovascular diseases are the primary cause of death worldwide, claiming approximately 17.9 million lives annually. In 2022, around 702,880 people died from heart disease in the U.S. which is equivalent of one in every five deaths. In addition, coronary heart disease is the most common type of heart disease. In 2022, around 371,506 died with coronary heart disease in the U.S.
With an aging population and increased lifestyle-related risk factors, the need for effective interventional cardiology solutions has surged. Moreover, increased healthcare expenditures and investments in medical technologies by hospitals and clinics are fostering market growth. Support from regulatory authorities, such as recent FDA and marketing approvals for new devices, enhances market accessibility and adoption. For instance, in March 2022, SIS Medical AG (Swiss Interventional Systems), one of the global manufacturers in interventional cardiology, announced the U.S. Food & Drug Administration's approval of its lead product, the OPN NC Super High Pressure PTCA Balloon Catheter.
One of the most notable advancements in the ultra-high pressure balloon catheter industry is the development of new materials and designs that improve the mechanical properties of the catheters. Manufacturers are investing in research and development to create ultra-thin, high-strength materials that can withstand higher pressures while maintaining a smaller profile. For instance, advancements in polymer technology have led to the creation of balloons that can expand significantly at high pressures without rupturing. This enables more effective dilatation of narrowed vessels, thereby improving the success rates of procedures. Manufacturers are increasingly offering a range of balloon sizes, shapes, and lengths that can cater to individual patient anatomies and specific clinical scenarios. This customization ensures that healthcare providers have the right tools at their disposal to address varying medical needs, promoting better procedural effectiveness and patient safety.
Ultra-High Pressure Balloon Catheter Market Report Highlights:
- Based on use, the therapeutic segment dominated the industry with the largest revenue share owing to the increasing prevalence of chronic diseases such as cardiovascular diseases, coupled with an aging population.
- Based on material, the nylon segment dominated the market with the largest revenue share as nylon is known for its high tensile strength, flexibility, and durability, making it an ideal choice for development of ultra-high pressure balloon catheters.
- Based on application, the nephrology segment is expected to witness significant growth during the forecast period owing to the rise in the prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), often resulting from conditions such as diabetes and hypertension, necessitating enhanced treatment options.
- Based on end use, the hospitals dominated the industry with the largest revenue share owing to increasing number of surgical procedures, advancements in technology, a growing preference for minimally invasive interventions, and improved patient care standards.
- North America dominated the ultra-high pressure balloon catheter industry with a share of 40.21% in 2024. This can be attributed to the combination of factors including the presence of key manufacturers, increasing prevalence of cardiovascular diseases, technological advancements, a robust healthcare infrastructure, and a growing preference for minimally invasive procedures.
- Market players operating in ultra-high pressure balloon catheters market include Boston Scientific Corporation; BD; BrosMed Medical Co., Ltd; Terumo Medical Corporation; SIS Medical AG; Merit Medical Systems; TT Medical, Zhejiang Barty Medical Technology Co., Ltd.
Table of Content
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Use
- 1.2.2. Material
- 1.2.3. Application
- 1.2.4. End Use
- 1.2.5. Regional Scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Ultra-High Pressure Balloon Catheter Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of cardiovascular diseases
- 3.2.1.2. Growing demand for minimally invasive procedures
- 3.2.1.3. Rising awareness of the benefits of advanced catheter technologies
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of procedures and devices
- 3.3. Ultra-High Pressure Balloon Catheter Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Ultra-High Pressure Balloon Catheter Market: Segment Analysis, By Use, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Use Market Share Analysis, 2024 & 2030
- 4.3. Global Ultra-High Pressure Balloon Catheter Market, by Use, 2018 to 2030
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 4.4.1. Diagnostic
- 4.4.1.1. Diagnostic market, 2018 - 2030 (USD Million)
- 4.4.2. Therapeutic
- 4.4.2.1. Therapeutic market, 2018 - 2030 (USD Million)
Chapter 5. Ultra-High Pressure Balloon Catheter Market: Segment Analysis, By Material, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. Materials Market Share Analysis, 2024 & 2030
- 5.3. Global Ultra-High Pressure Balloon Catheter Market, by Materials, 2018 to 2030
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 5.4.1. Nylon
- 5.4.1.1. Nylon market, 2018 - 2030 (USD Million)
- 5.4.2. Polyester
- 5.4.2.1. Polyester market, 2018 - 2030 (USD Million)
Chapter 6. Ultra-High Pressure Balloon Catheter Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 6.1. Definition and Scope
- 6.2. Application Market Share Analysis, 2024 & 2030
- 6.3. Global Ultra-High Pressure Balloon Catheter Market, by Application, 2018 to 2030
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 6.4.1. Cardiology
- 6.4.1.1. Cardiology market, 2018 - 2030 (USD Million)
- 6.4.2. Urology
- 6.4.2.1. Urology market, 2018 - 2030 (USD Million)
- 6.4.3. Nephrology
- 6.4.3.1. Nephrology market, 2018 - 2030 (USD Million)
- 6.4.4. Others
- 6.4.4.1. Others market, 2018 - 2030 (USD Million)
Chapter 7. Ultra-High Pressure Balloon Catheter Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 7.1. Definition and Scope
- 7.2. End Use Market Share Analysis, 2024 & 2030
- 7.3. Global Ultra-High Pressure Balloon Catheter Market, by End Use, 2018 to 2030
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 7.4.1. Hospitals
- 7.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
- 7.4.2. Ambulatory Surgical Centers (ASCs)
- 7.4.2.1. Ambulatory Surgical Centers (ASCs) market, 2018 - 2030 (USD Million)
- 7.4.3. Specialty Clinics
- 7.4.3.1. Specialty clinics market, 2018 - 2030 (USD Million)
- 7.4.4. Others
- 7.4.4.1. Others market, 2018 - 2030 (USD Million)
Chapter 8. Ultra-High Pressure Balloon Catheter Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 8.3. North America
- 8.3.1. U.S.
- 8.3.1.1. Key country dynamics
- 8.3.1.2. Regulatory framework/ reimbursement structure
- 8.3.1.3. Competitive scenario
- 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.2. Canada
- 8.3.2.1. Key country dynamics
- 8.3.2.2. Regulatory framework/ reimbursement structure
- 8.3.2.3. Competitive scenario
- 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Regulatory framework/ reimbursement structure
- 8.4.1.3. Competitive scenario
- 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Regulatory framework/ reimbursement structure
- 8.4.2.3. Competitive scenario
- 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3. France
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Regulatory framework/ reimbursement structure
- 8.4.3.3. Competitive scenario
- 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.4. Italy
- 8.4.4.1. Key country dynamics
- 8.4.4.2. Regulatory framework/ reimbursement structure
- 8.4.4.3. Competitive scenario
- 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.5. Spain
- 8.4.5.1. Key country dynamics
- 8.4.5.2. Regulatory framework/ reimbursement structure
- 8.4.5.3. Competitive scenario
- 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.6. Norway
- 8.4.6.1. Key country dynamics
- 8.4.6.2. Regulatory framework/ reimbursement structure
- 8.4.6.3. Competitive scenario
- 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Key country dynamics
- 8.4.7.2. Regulatory framework/ reimbursement structure
- 8.4.7.3. Competitive scenario
- 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key country dynamics
- 8.4.8.2. Regulatory framework/ reimbursement structure
- 8.4.8.3. Competitive scenario
- 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. China
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. India
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.4. Australia
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Regulatory framework/ reimbursement structure
- 8.5.4.3. Competitive scenario
- 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Regulatory framework/ reimbursement structure
- 8.5.5.3. Competitive scenario
- 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.6. Thailand
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Regulatory framework/ reimbursement structure
- 8.5.6.3. Competitive scenario
- 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Argentina
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. MEA
- 8.7.1. South Africa
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. UAE
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Kuwait
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Recent Developments & Impact Analysis by Key Market Participants
- 9.3. Company Market Share Analysis, 2024
- 9.4. Key Company Profiles
- 9.4.1. Boston Scientific Corporation
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Terumo Medical Corporation
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Merit Medical Systems
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. BD
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. BrosMed Medical Co., Ltd
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. SIS Medical AG
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. TT Medical
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Zhejiang Barty Medical Technology Co., Ltd
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product benchmarking
- 9.4.8.4. Strategic initiatives